Announcing Cell Reports - a new open-access journal from Cell Press
From the evolution of polar bears to the structure of a nuclear pore complex, Cell Reports will publish the highest-quality research
Cambridge, MA, August 1, 2011, Cell Press announced today the launch of its newest journal, Cell Reports, which will publish its first issue in January 2012. Cell Reports, the first open-access online-only journal from Cell Press, will publish high-quality research across the entire life science spectrum. The journal will focus on shorter, single-point articles, entitled Reports, in addition to regular full-length articles. As with all Cell Press journals, the primary criterion for both formats will be new biological insight.
Cell Press journals have always placed a high priority on ensuring sustainable access to content by offering free featured articles and providing sponsored-access opportunities, as well as by making all content freely available after 12 months. Cell Reports builds on this commitment and provides authors with the option to publish in a prestigious journal with immediate fully-available global access. Authors will retain full copyright over their articles, and they will be able to choose between two Creative Commons icenses for publication, one of which is the most permissive license that Creative Commons offers.
“Cell Press is ideally placed to create a top-tier journal with a sustainable open-access model. By tapping into our extensive in-house expertise, we can deliver a fast, informed, high-quality review process across a broad range of disciplines," said Emilie Marcus, Editor-in-Chief of Cell Press and Editor of Cell. "In addition, we have an excellent track record of launching successful highly-regarded journals even in very competitive arenas, and authors and readers can expect nothing less from Cell Reports."
Boyana Konforti is the Editor of Cell Reports. Boyana earned her Ph.D. at Stanford University with Ron Davis, studying the mechanism of DNA recombination. She then did postdoctoral studies on the mechanisms of RNA splicing at Rockefeller University with Magda Konarska and at Columbia University with Anna Pyle. Boyana has been a professional editor for over 13 years, and she brings a wealth of experience in scientific journal publishing, as well as a deep understanding of biology and the communities that Cell Press serves. “An exciting feature will be ourunique editorial board, which will consist of up-and-coming scientists who are the new leaders in their respective fields and will help shape the journal from the ground up,” said Boyana.
Cell Reports is now accepting papers for consideration in volume 1, scheduled to publish in January 2012. Visit www.cell.com/cell-reports to learn more about Cell Reports.
# # #
About Cell Press
Cell Press is committed to improving scientific communication through the publication of exciting research and reviews. As we introduce publications and expand our online content to serve our growing audience, our mission remains to publish and develop journals that deliver the highest possible intellectual rigor, promote community trust, and are widely disseminated. Cell Press primary research journals include the flagship journal Cell. For more information, please visit www.cell.com.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
Elisabeth (Lisa) Lyons
Press Office, Cell Press